focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,333.00
Bid: 2,340.00
Ask: 2,341.00
Change: -19.00 (-0.81%)
Spread: 1.00 (0.043%)
Open: 2,342.00
High: 2,354.00
Low: 2,333.00
Prev. Close: 2,352.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
5th May 201112:01 pmRNSHolding(s) in Company
4th May 20113:54 pmRNSDirector/PDMR Shareholding
3rd May 201110:46 amRNSTotal Voting Rights
4th Apr 201110:29 amRNSTotal Voting Rights
28th Mar 20114:26 pmRNSTreasury Stock
9th Mar 20117:00 amRNSAcquisition
2nd Mar 20112:33 pmRNSDirector/PDMR Shareholding
2nd Mar 201110:07 amRNSTotal Voting Rights
2nd Mar 20118:47 amRNSAcquisition
17th Feb 20117:00 amRNSInterim Management Statement
15th Feb 20112:42 pmRNSHolding(s) in Company
4th Feb 20118:45 amRNSTotal Voting Rights
25th Jan 20112:23 pmRNSBlocklisting Interim Review
19th Jan 20115:56 pmRNSTreasury Stock
4th Jan 20115:17 pmRNSTotal Voting Rights
17th Dec 20107:00 amRNSAcquisition
8th Dec 201011:44 amRNSDirector/PDMR Shareholding
2nd Dec 20103:53 pmRNSTreasury Stock
1st Dec 201010:25 amRNSTotal Voting Rights
30th Nov 201011:07 amRNSDoc re. Half Year Report 2010/11
30th Nov 20107:00 amRNSHalf Yearly Report
24th Nov 201011:22 amRNSNotice of Results
5th Nov 20104:02 pmRNSTreasury Stock
3rd Nov 20107:00 amRNSAcquisition
1st Nov 20103:51 pmRNSTotal Voting Rights
6th Oct 20104:36 pmRNSHolding(s) in Company
5th Oct 20104:19 pmRNSDirector/PDMR Shareholding
5th Oct 20102:12 pmRNSHolding(s) in Company
4th Oct 201010:11 amRNSTotal Voting Rights
29th Sep 20102:46 pmRNSTreasury Stock
7th Sep 20105:53 pmRNSDirector/PDMR Shareholding
2nd Sep 20105:12 pmRNSTotal Voting Rights
11th Aug 20104:26 pmRNSAnnual Information Update
11th Aug 20103:50 pmRNSBlocklisting Interim Review
9th Aug 20109:24 amRNSDirector/PDMR Shareholding
6th Aug 20104:35 pmRNSPrice Monitoring Extension
3rd Aug 20103:24 pmRNSDirector/PDMR Shareholding
2nd Aug 201012:55 pmRNSTotal Voting Rights
30th Jul 20104:37 pmRNSHolding(s) in Company
30th Jul 20102:14 pmRNSDirectorate Change
30th Jul 201012:52 pmRNSResult of AGM
29th Jul 20107:00 amRNSAGM Statement
7th Jul 201010:03 amRNSDirector/PDMR Shareholding
7th Jul 20109:46 amRNSTreasury Stock
6th Jul 20109:27 amRNSDirectorate Change
5th Jul 20104:45 pmRNSHolding(s) in Company
1st Jul 20103:13 pmRNSTotal Voting Rights
1st Jul 20103:13 pmRNSTotal Voting Rights
28th Jun 201011:39 amRNSAnnual Financial Report
22nd Jun 20107:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.